companydata.dkcompanydata.dk

Nykode Therapeutics Denmark A/S: Financial statements 2025

CVR: 42038660

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Nykode Therapeutics Denmark A/S (CVR 42038660) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 31,839,001 and a net result of DKK 1,347,127 compared with DKK 156,959 the year before. That is a decrease of 49.9% compared with the year before. Equity in the 2025 report amounted to DKK 6,862,099. The solvency ratio was 44.1%. The company had 16 employees in the financial year.

Gross Profit
DKK 31,839,001
Profit/Loss
DKK 1,347,127
Equity
DKK 6,862,099
Total Assets
DKK 15,551,490
Employees
16

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-31.8M1.3M6.9M16
2024-63.6M157K5.5M31
2023-52.9M2.5M5.4M31
2022-38.6M1.9M2.9M23
2021-10.6M578K978K7

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Nykode Therapeutics Denmark A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Nykode Therapeutics Denmark A/S: The 2024 annual report is outMay 23, 2025

Nykode Therapeutics Denmark A/S has published its annual report for 2024. Gross profit came to DKK 63,552,511, and the net result was DKK 156,959.

About Nykode Therapeutics Denmark A/S

Nykode Therapeutics Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Vaccibody Denmark A/S. The management consists of Michael Thyrring Engsig. The board consists of Louise Stubbe (chair), Harald Gurvin and Michael Thyrring Engsig. The company is owned by Nykode Therapeutics ASA. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 31,839,001 and a net result of DKK 1,347,127 compared with DKK 156,959 the year before. Equity in the 2025 report amounted to DKK 6,862,099.

Source: annual report 2025, Danish Business Authority

Other financial years